On March 22, 2018, the European Parliament’s (EP) Committee on Petitions (PETI) and Committee on the Environment, Public Health and Food Safety (ENVI) held a joint public hearing on the impact of endocrine disrupting chemicals (EDCs) on public health and the environment.
Presentations were held by Conor Clenaghan from the European Chemicals Agency (ECHA), Alice Bernard from non-profit environmental law organization ClientEarth, Natacha Cingotti from non-profit organization Health and Environment Alliance (HEAL), Alberto Mantovani from the Italian National Institute of Health, Istituto Superiore di Sanità, and Daniel Dietrich from the University of Konstanz, Germany. The hearing was held “due to the high number of petitions received on the topic” and consisted of two panels: One focused on “the specificities of the EU regulatory approval process for EDCs,” and the other on whether the regulatory approach “could be conceived differently in the future.”
The video recording of the hearing can be watched on-demand on the EP’s website.
European Parliament Committees (March 22, 2018). “22-03-2018 – Hearing: Impact of endocrine disruptors on public health.”
HEAL (April 3, 2018). “Public hearing in the European Parliament on EDCs, public health and the environment.“